
    
      after being informed and about the study and potential risks, all patients giving written
      informed consent will undergo 24 hours screening period to determine the eligilibity for
      study entry. After a computer-generated randomization list with a 1:1 intergroup ratio,
      ensuring equal distribution in the two groups, 30 opaque sealed envelopes numbered 1-30 were
      prepared. The patients were randomly divided into the Group with bilateral CPB with 15 ml
      0.5% bupivacaine or the patients with translaryngeal block with 5 ml 2% lidocaine in addition
      to bilateral CPB.

      CPB: cervical plexus block.
    
  